CVE-2026-123218: Authorization Bypass and Administrative Privilege Escalation in IBM Aspera Faspex
- Vendor
- International Business Machines
CVE-2026-123218 is an incorrect authorization vulnerability in IBM Aspera Faspex versions 5.0.0 through 5.0.19. An authenticated user can submit a specially crafted message that bypasses application authorization checks and grants full Faspex administrative privileges. The affected endpoint, message fields, and vulnerable function have not been identified publicly. The vulnerability is fixed in version 5.0.19 PL1.
Impact, mitigation & remediation
What it means and what to do now: patch path, interim mitigations, and the assume-compromise checklist.
Impact
What an attacker gets, and what they’ve been doing with it.
Successful exploitation compromises application-level access controls, allowing an authenticated user to obtain full Faspex administrative privileges. This can expose sensitive information and permit unauthorized modification of application configuration or disruption of service, with potentially high confidentiality, integrity, and availability impacts. Operating system command execution and root access to the underlying host are not established.
Mitigation
If you can’t patch tonight, do this now.
IBM lists no vendor-approved workarounds or alternative mitigations. Until patching is completed, restrict access to affected deployments to trusted users and monitor for unexpected administrative privilege changes. These precautions do not correct the authorization flaw or replace the update.
Remediation
Patch, then assume compromise.
Upgrade affected deployments to IBM Aspera Faspex 5.0.19 PL1 or a later vendor-confirmed fixed release using IBM's installation instructions. Verify that the running faspex-core container reports version 5.0.19, build identifier 1ce4b13, and Fix Pack 1 when installing PL1. Checking the main version number alone is insufficient because vulnerable and corrected releases both report 5.0.19. Perform forensic triage for possible prior compromise alongside remediation.
Exploits
No validated public exploits yet. Hidden: 1 rejected by Mallory's analysis as not a working exploit.
Affected products & vendors
Products and vendors Mallory has correlated with this vulnerability. Open in Mallory to drill down to specific CPE configurations and version ranges.
Frequently asked questions
- Is CVE-2026-123218 exploited in the wild?
- Yes. As of Nov 15, 2026, Mallory has reports of exploitation in the wild, and CISA added it to KEV on Nov 9, 2026.
- Is there a public exploit for CVE-2026-123218?
- As of Nov 15, 2026, Mallory has found no public exploit for CVE-2026-123218.
- Is there a patch for CVE-2026-123218?
- Upgrade affected deployments to IBM Aspera Faspex 5.0.19 PL1 or a later vendor-confirmed fixed release using IBM's installation instructions. Verify that the running faspex-core container reports version 5.0.19, build identifier 1ce4b13, and Fix Pack 1 when installing PL1.
- What products are affected by CVE-2026-123218?
- International Business Machines Aspera Faspex.
- How severe is CVE-2026-123218?
- CVE-2026-123218 has a CVSS v3.1 score of 9.8 (Critical) and an EPSS score of 0.53% (46th percentile) as of Nov 15, 2026.
Recent activity
80 sources tracked across advisories, community write-ups, and news. New activity surfaces here as Mallory finds it.